Go Deep
Bio-Techne Corporation
Bio-Techne Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,070 | 62.5 | 5.39 | 0.14 | 6,997.33 |
| Oct 2026 | 18,056 | 62.6 | 5.40 | 0.14 | 6,946.93 |
| Oct 2026 | 18,133 | 62.5 | 5.39 | 0.14 | 6,902.54 |
| Oct 2026 | 18,131 | 62.5 | 5.39 | 0.14 | 6,883.69 |
| Oct 2026 | 18,129 | 62.5 | 5.39 | 0.14 | 6,886.57 |
| Oct 2026 | 18,123 | 62.6 | 5.40 | 0.14 | 6,873.46 |
| Oct 2026 | 18,132 | 62.5 | 5.39 | 0.14 | 6,873.24 |
| Oct 2026 | 18,122 | 62.6 | 5.40 | 0.14 | 6,881.77 |
| Oct 2026 | 18,116 | 62.6 | 5.40 | 0.14 | 6,870.45 |
| Oct 2026 | 18,118 | 62.6 | 5.40 | 0.14 | 6,854.66 |
| Oct 2026 | 18,125 | 62.5 | 5.40 | 0.14 | 6,876.45 |
Bio-Techne Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 321,192,000.0 | 311,415,000.0 | 295,877,000.0 | 286,555,000.0 |
| Net Profit | 54,621,000.0 | 51,047,000.0 | 38,009,000.0 | 38,185,000.0 |
| EPS | 0.3 | 0.3 | 0.2 | 0.2 |
Bio-Techne Corporation Revenue & Profit: Last 5 Years
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Revenue | 1,215,039,000.0 | 1,219,635,000.0 | 1,159,060,000.0 | 1,136,702,000.0 | — |
| Net Profit | 181,862,000.0 | 73,400,000.0 | 168,105,000.0 | 285,263,000.0 | — |
| EPS | 1.2 | 0.5 | 1.1 | 1.8 | — |
Bio-Techne Corporation Balance Sheet
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Total Assets | 2,586,726,000.0 | 2,557,868,000.0 | 2,703,867,000.0 | 2,638,692,000.0 | — |
| Total Liabilities | 478,505,000.0 | 639,060,000.0 | 635,017,000.0 | 672,176,000.0 | — |
| Total Equity | 2,108,221,000.0 | 1,918,808,000.0 | 2,068,850,000.0 | 1,966,516,000.0 | — |
Owes vs Owns
Bio-Techne Corporation owed $0.18 for every $1 it owned in Jun 2026, down from $0.25 in Jun 2023.
| Period | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.18× | 0.25× | 0.23× | 0.25× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Bio-Techne Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Jun 2026
Cash & short-term investments 10.2%Receivables 8.4%Inventory 7.6%Fixed assets (tangible) 11.6%Intangible assets 49.4%Long-term investments 9.5%Other assets 3.3%
How it's funded — Jun 2026
Short-term debt 0.6%Long-term debt 7.7%Payables 1.0%Other liabilities 9.2%Shareholders' equity 81.5%
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 264.7 | 162.2 | 152.9 | 204.3 |
| Receivables | 216.6 | 206.9 | 241.4 | 218.5 |
| Inventory | 195.7 | 189.4 | 179.7 | 171.6 |
| Fixed assets (tangible) | 299.2 | 319.1 | 342.4 | 324.5 |
| Intangible assets | 1,278.8 | 1,346.5 | 1,479.7 | 1,407.4 |
| Long-term investments | 245.8 | 251.0 | 242.3 | 255.9 |
| Other assets | 85.9 | 82.7 | 65.4 | 56.5 |
| Liabilities & equity | ||||
| Short-term debt | 14.9 | 14.1 | 12.9 | 11.2 |
| Long-term debt | 200.0 | 346.0 | 319.0 | 350.0 |
| Payables | 26.7 | 25.3 | 38.0 | 25.7 |
| Other liabilities | 236.9 | 253.7 | 265.1 | 285.3 |
| Shareholders' equity | 2,108.2 | 1,918.8 | 2,068.8 | 1,966.5 |
| Net tangible assets | 829.4 | 572.3 | 589.1 | 559.1 |
Bio-Techne Corporation Cash Flow
| Line Item | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Operating Activities | 292,073,000.0 | 287,556,000.0 | 298,981,000.0 | 254,393,000.0 | — |
| Investing Activities | -18,190,000.0 | -35,183,000.0 | -203,030,000.0 | -265,649,000.0 | — |
| Financing Activities | -169,114,000.0 | -253,905,000.0 | -122,398,000.0 | 22,616,000.0 | — |